On June 30, 2026, Arlo Technologies Inc (ARLO) shares rose 3.3% today, closing at $13.48. The stock has exhibited a 52-week range between $11.05 and $19.94. Thi

Aloe Care Health Connect AI wellness and adherence solution will enable proactive conversations and keep families, caregivers and home care providers connected at scale. SAN JOSE, Calif.

Smart Home Security Service Leader Places in Top 10 of Appliances & Electronics Category SAN JOSE, Calif., June 16, 2026 /PRNewswire/ -- Arlo Technologies, Inc.

Arlo Technologies remains a compelling small-cap buy, leveraging strong subscriber growth and a strategic expansion into senior care via the Aloe Care acquisition. ARLO posted Q1 revenue of $150.4M (+26% y/y), surpassing both company guidance and Wall Street expectations, with paid subscribers exceeding 6 million and churn at just 1.0%. Subscription revenue growth and rising ARPU drove annual recurring revenue to $357M (+29% y/y), while gross margin expanded to 50.1% and adjusted EBITDA margin hit 20.2%.

The market is still treating Arlo Technologies and Evolv Technologies as speculative hardware plays, but both are building sticky AI-powered subscription businesses that could be dramatically bigger a few years from now.

On May 22, 2026, Arlo Technologies Inc (ARLO) shares rose 3.4% to $13.16. This increase comes in the context of a 52-week trading range of $11.05 to $19.94. The

Arlo Technologies NYSE: ARLO reported record first-quarter 2026 revenue and earnings, with management pointing to rapid growth in paid accounts, higher average revenue per user and expanding services margins as the main drivers of the quarter.

Arlo Technologies, Inc. (ARLO) Q1 2026 Earnings Call Transcript

While the top- and bottom-line numbers for Arlo Technologies (ARLO) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Arlo Technologies (ARLO) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.15 per share a year ago.